Archive for the ‘biotech/medical’ category: Page 11

Jan 1, 2023

Stanford researchers think a wireless brain implant could remove tumors

Posted by in categories: biotech/medical, neuroscience

𝐒𝐭𝐚𝐧𝐟𝐨𝐫𝐝 𝐫𝐞𝐬𝐞𝐚𝐫𝐜𝐡𝐞𝐫𝐬 𝐭𝐡𝐢𝐧𝐤 𝐚 𝐰𝐢𝐫𝐞𝐥𝐞𝐬𝐬 𝐛𝐫𝐚𝐢𝐧 𝐢𝐦𝐩𝐥𝐚𝐧𝐭 𝐜𝐨𝐮𝐥𝐝 𝐫𝐞𝐦𝐨𝐯𝐞 𝐭𝐮𝐦𝐨𝐫𝐬

𝙍𝙚𝙨𝙚𝙖𝙧𝙘𝙝𝙚𝙧𝙨 𝙖𝙩 𝙎𝙩𝙖𝙣𝙛𝙤𝙧𝙙 𝙈𝙚𝙙𝙞𝙘𝙞𝙣𝙚 𝙝𝙖𝙫𝙚 𝙙𝙚𝙫𝙚𝙡𝙤𝙥𝙚𝙙 𝙖 𝙨𝙢𝙖𝙡𝙡 𝙬𝙞𝙧𝙚𝙡𝙚𝙨𝙨 𝙙𝙚𝙫𝙞𝙘𝙚 𝙩𝙝𝙖𝙩 𝙘𝙤𝙪𝙡𝙙 𝙬𝙞𝙧𝙚𝙡𝙚𝙨𝙨𝙡𝙮 𝙧𝙚𝙢𝙤𝙫𝙚 𝙙𝙚𝙖𝙙𝙡𝙮 𝙗𝙧𝙖𝙞𝙣 𝙩𝙪𝙢𝙤𝙧𝙨.

Researchers think a wireless implant to treat brain tumors could eliminate hospital visits for cancer treatment. [Image courtesy of Stanford Medicine]

Continue reading “Stanford researchers think a wireless brain implant could remove tumors” »

Jan 1, 2023

Researchers develop new software for unlocking cancer’s ancestry

Posted by in categories: biotech/medical, genetics

Could knowing where your ancestors came from be the key to better cancer treatments? Maybe, but where would that key fit? How can we trace cancer’s ancestral roots to modern-day solutions? For Cold Spring Harbor Laboratory (CSHL) Research Professor Alexander Krasnitz, the answers may lie deep within vast databases and hospital archives containing hundreds of thousands of tumor samples.

Krasnitz and CSHL Postdoctoral Fellow Pascal Belleau are working to reveal the genealogical connections between and race or ethnicity. They’ve developed new software that accurately infers continental from tumor DNA and RNA. Their latest study is published in Cancer Research, and their work may help clinicians develop new strategies for early cancer detection and personalized treatments.

“Why do people of different races and ethnicities get sick at different rates with different types of cancer? They have different habits, living conditions, exposures—all kinds of social and . But there may be a as well,” Krasnitz says.

Jan 1, 2023

David Sinclair’s AMA: Age Reversal Breakthroughs, FDA Approval, and Living Forever

Posted by in categories: biotech/medical, genetics, life extension, Peter Diamandis

The whole interview is good and informative but starts with Sinclair commenting that at the moment he thinks living to 150 is possible in our lifetimes but not immortality. But given that, I’m 51. If I’m going to live potentially another century the technology will get better and better in that century and I would fully expect to life spans to become what we want rather than what we have to accept.

In this Ask Me Anything session, David and Peter discuss the latest age-reversal breakthroughs, getting approval from the FDA, and the possibility of living forever.
David Sinclair is a biologist and academic known for his expertise in aging and epigenetics. Sinclair is a genetics professor and the Co-Director of Harvard Medical School’s Paul F. Glenn Center for Biology of Aging Research. He’s been included in Time100 as one of the 100 Most Influential People in the World, and his research has been featured all over the media. Besides writing a New York Times Best Seller, David has co-founded several biotech companies, a science publication called Aging, and is an inventor of 35 patents.
Read David’s book, Lifespan: Why We Age-and Why We Don’t Have To:

Continue reading “David Sinclair’s AMA: Age Reversal Breakthroughs, FDA Approval, and Living Forever” »

Jan 1, 2023

Why scientists dug up the father of genetics, Gregor Mendel, and analyzed his DNA

Posted by in categories: biotech/medical, genetics

The year 2022 was the 200th anniversary of the birth of Gregor Mendel. He’s known as the father of genetics, so scientists exhumed Mendel’s body and examined his DNA.

Jan 1, 2023

Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly

Posted by in categories: biotech/medical, health

The Covid omicron XBB.1.5 variant is rapidly becoming dominant in the U.S. because it is highly immune evasive and appears more effective at binding to cells than related subvariants, scientists say.

XBB.1.5 now represents about 41% of new cases nationwide in the U.S., nearly doubling in prevalence over the past week, according to the data published Friday by the Centers for Disease Control and Prevention. The subvariant more than doubled as a share of cases every week through Dec. 24. In the past week, it nearly doubled from 21.7% prevalence.

Scientists and public health officials have been closely monitoring the XBB subvariant family for months because the strains have many mutations that could render the Covid-19 vaccines, including the omicron boosters, less effective and cause even more breakthrough infections.

Continue reading “Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly” »

Jan 1, 2023

Genomics pioneer George Church, former Kindred Bio execs launch CRISPR-designed pets company AdoraPet Biosciences

Posted by in categories: bioengineering, biotech/medical, existential risks, genetics

A Peninsula biotech startup cofounded by pioneering geneticist George Church — who already is working to engineer the woolly mammoth out of extinction — is trying to raise as much as $5 million in a crowdfunding effort to design healthier, longer-living pets.

AdoraPet Biosciences Inc. of San Mateo plans to apply the genome-engineering CRISPR technology at the egg stage of dogs and cats or insert CRISPR-modified DNA into eggs, to make nonallergenic pets that don’t shed and ultimately live longer, are free of genetic diseases caused by inbreeding and are resistant to cancer and other serious diseases.

Dec 31, 2022

Scientists remotely controlled the social behavior of mice with light

Posted by in categories: biotech/medical, genetics, neuroscience

Year 2021 Basically this could cure many diseases and even allow for better human devices to be created.

New devices — worn as headsets and backpacks — rely on optogenetics, in which bursts of light toggle neurons, to control mouse brain activity.

Dec 31, 2022

Researchers From Japan Discovered That The Juice Of This Fruit May Inhibit Lung Cancer In Mice

Posted by in category: biotech/medical

Lung cancer is the third most common cancer in the United States, following skin and breast cancers– with over two hundred and thirty-six thousand cases diagnosed in 2022 alone, according to the American Cancer Society. The most significant risk factor includes smoking, with eighty to ninety percent of all lung cancer deaths being linked to smoking in the U.S. Other contributing factors include secondhand smoke, the inhalation of radon– a naturally occurring gas– and familial history of lung cancer.

Dec 31, 2022

Surprising Findings — Ancient Disease Has the Potential To Regenerate a Vital Organ

Posted by in categories: biotech/medical, life extension

Leprosy is a chronic infectious disease caused by the bacterium Mycobacterium leprae. It affects the skin, nerves, and mucous membranes, and can lead to severe disfigurement and disability if left untreated.

Leprosy, a chronic infectious disease caused by the bacterium Mycobacterium leprae, is one of the oldest and most persistent diseases in the world. However, new surprising research suggests that the bacteria that cause leprosy may also have the ability to stimulate the growth and regeneration of the liver in adult animals without causing damage or scarring. Scientists have discovered that parasites associated with leprosy can reprogram cells to increase the size of the liver.

The findings suggest the potential to use this natural process to rejuvenate aging livers and extend the period of disease-free living in humans, known as healthspan. It may also be possible to use this process to regenerate damaged livers, potentially reducing the need for liver transplantation, which is currently the only effective treatment for individuals with severely scarred livers.

Continue reading “Surprising Findings — Ancient Disease Has the Potential To Regenerate a Vital Organ” »

Dec 31, 2022

Applying CRISPR Tech to Edit the Code of Life | Dr. Jennifer Doudna | GZERO World with Ian Bremmer

Posted by in categories: biotech/medical, genetics

Nobel winner Jennifer Doudna explains CRISPR, the gene-editing technology she pioneered.

Berkeley scientist Jennifer Doudna won the 2020 Nobel Prize for her work on the revolutionary gene-editing technology known as CRISPR. It has the potential to cure genetic diseases like sickle cell anemia and hereditary blindness and may even be used to treat cancer and HIV. But when it comes to editing humanity, where do we draw the line? How do we avoid falling into the same kind of dystopian nightmare outlined in Blade Runner? Doudna discussed the risks and benefits of CRISPR in an interview with Ian Bremmer on GZERO World. Also in this episode: a look at cloning our pets (speaking of going too far…).

Continue reading “Applying CRISPR Tech to Edit the Code of Life | Dr. Jennifer Doudna | GZERO World with Ian Bremmer” »

Page 11 of 1,981First89101112131415Last